GIL-100 Sales and Investment Attractiveness Index for Healthcare

Country Attractiveness for Healthcare

USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

Where should one invest or sell in the aftermath of the financial crisis of 2008 and the on-going European debt crisis? While rich countries have shown very slow growth rates, emerging markets have shown much greater resilience. To increase profitability, you can either find new markets to increase sales, or seek opportunities to invest. Emerging markets will help you do both. The GIL-100 HC Sales and Attractiveness Indices is a generalized model and can be specifically engineered for client growth objectives.

Table of Contents

GIL-100 Sales and Investment Attractiveness Index for HealthcareGIL-100 Sales and Investment Attractiveness IndexGIL-100 HC Index- Methodology and Case Studies




Related Research

Release Date : 14-Feb-18

Region : Global

Release Date : 12-Feb-18

Region : Global

Release Date : 09-Feb-18

Region : Global

Release Date : 09-Feb-18

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.